Case Number:

IPR2021-01272

Case Type:

IPR

Status:

Trial Instituted

Petitioner:

Illumina, Inc.

Patent Owner:

Ravgen, Inc.

Tech Center:

1600

1. Filed: July 20, 2021 00:00

   Coverage

   1. January 26, 2023

      PTAB Upholds Testing Patents After Ravgen's $272M Jury Win

      The Patent Trial and Appeal Board has rebuffed biotechnology company Illumina's bid to ax two genetic testing patents that have been asserted against it and others by rival Ravgen in federal suits, buttressing a product at the center of a $272 million infringement verdict Ravgen won last year.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login